Cargando…
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer
In cancer patients, the clinical response to checkpoint-based immunotherapy is associated with the composition and functional quality of the host microbiome. While the relevance of the gut microbiome for checkpoint immunotherapy outcome has been addressed intensively, data on the role of the local t...
Autores principales: | Boesch, Maximilian, Baty, Florent, Albrich, Werner C., Flatz, Lukas, Rodriguez, Regulo, Rothschild, Sacha I., Joerger, Markus, Früh, Martin, Brutsche, Martin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667931/ https://www.ncbi.nlm.nih.gov/pubmed/34912592 http://dx.doi.org/10.1080/2162402X.2021.1988403 |
Ejemplares similares
-
Tumour neoantigen mimicry by microbial species in cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2021) -
Non-pharmaceutical interventions to optimize cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2023) -
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
por: Baty, Florent, et al.
Publicado: (2017) -
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
por: Boesch, Maximilian, et al.
Publicado: (2022) -
EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
por: Baty, Florent, et al.
Publicado: (2013)